USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immatics Biotechnologies Gmbh

USPTO PatentsView assignee record - 690 granted patents across 15 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

690

Total patents granted

CPC technology areas

18.8

Avg claims per patent

+147%

5-year filing velocity

The verdict

Immatics holds 690 US patents across 15 technology areas, rank #648 of 50,000 tracked assignees.

#648
of 50,000 US assignees by volume: Top 12%
by Innovation Score (51.0/100): 18.8
avg claims per patent: +147%
filing velocity, last 5 yrs

Portfolio overview

Immatics Biotechnologies Gmbh has been granted 690 US utility patents between 2015 and 2025, placing Immatics Biotechnologies Gmbh at rank #648 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Immatics Biotechnologies Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Immatics sits between Cameron International Corporation (692 patents, rank #644) and The Research Foundation For The State University Of New York (688 patents, rank #652) - the closest US assignees by grant volume. The composite Innovation Score of 51.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 491 grants, compared with 199 in the 2015–2019 window, a +147% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Immatics Biotechnologies Gmbh's 18.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Immatics Biotechnologies Gmbh against peers pursuing similar technology classes.

Cameron Internati…

692
Posco

691
Schneider Electri…

691
University of Was…

691
Rivian IP Holdings

690
Immatics Biotechn… ◀

690
Carl Zeiss Meditec

689
Saturn Licensing

689
The Research Foun…

688

What this shows Immatics holds 690 patents at rank #648, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immatics

By rank, the assignees closest to #648 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Immatics's primary technology class.

Immatics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immatics Biotechnologies Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	1.2%
2016	6	0.9%
2017	7	1.0%
2018	63	9.1%
2019	115	16.7%
2020	128	18.6%
2021	124	18.0%
2022	64	9.3%
2023	51	7.4%
2024	79	11.4%
2025	45	6.5%

Which technologies does Immatics Biotechnologies Gmbh patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 680

C07K - PEPTIDES 678

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 651

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 647

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 395

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 286

C12Y - ENZYMES 117

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 107

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 53

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 42

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 16

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 14

G16C - COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE 8

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#648

Across all tracked assignees

Innovation Score

51.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Immatics Biotechnologies Gmbh hold?

Immatics Biotechnologies Gmbh holds 690 US granted patents filed between 2015 and 2025, spanning 15 technology areas.

What is Immatics Biotechnologies Gmbh's Innovation Score?

Immatics Biotechnologies Gmbh has an Innovation Score of 51.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immatics Biotechnologies Gmbh focus on?

Immatics Biotechnologies Gmbh's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 680 patents. The company has filed patents in 15 CPC subclasses total.

Is Immatics Biotechnologies Gmbh's patent filing rate increasing or decreasing?

Immatics Biotechnologies Gmbh's recent filing velocity is +147% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Immatics Biotechnologies Gmbh's patents?

Immatics Biotechnologies Gmbh's patents average 18.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Immatics Biotechnologies Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Immatics's 690 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Immatics ranks #648 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.